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The composition of the skin secretion of Bufo viridis 
toads, which inhabit the Kharkov region, has been stud- 
ied in this work. Interest in naturally occurring bufadieno- 
lides [1] is due to their cardiotonic and local anesthetic 
activity [2]. Moderate antiviral and antileukemic activity 
has been detected in bufadienolides [3]. We have isolated 
nine bufadienolides ( I -  IX) from the steroid fraction of 
the secretion using column and preparative HPLC. Charac- 
teristic signals for the pyrone ring protons were present at 
6.2 -7.8 ppm in the PMR spectra of all these compounds 
[4]. Compound I has the composition C24H3404 (MH + = 387) 
according to data of elemental nalysis and mass spectrome- 
try. Its PMR spectrum agrees with the spectrum of bu- 
falin [5]. Compound II has the composition C24H3205 
(MH + = 401). The characteristic signal for a proton in an 
epoxide ring is present at 3.51 ppm in its PMR spec- 
trum. This compound corresponds to marinobufagin i its 
characteristics [5]. 
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Compounds I I I -V  have the compoSition C24H3405 
(MH += 403) and are all trihydroxy compounds. It follows 
from the PMR spectrum of compound III that there is only one 
secondary hydroxyl group in this compound (br. s. 3ct-H at 
4.11 ppm), consequently III is teloclnobufagin, itsm. p. and 
PMR spectrum correspond tothe literature data in [3]. Signals 
are present in the RMR spectrum of compound IV for two 
protons at secondary hydroxyl groups, a broadened singlet for 
the 3ct-H at 4.15 ppm and a multiplet at 3.8 ppm (3j = 4, I0, 
and 10 Hz). The chemical shift and coupling constants of the 
latter are characteristic for the geminal proton at the 1 lct-hy- 
droxyl group. Consequently compound IV is gamabufotalin, 
which was then confirmed by an x-ray structural investigation. 
The third hydroxyl group of compound V is located at 
C-19 as indicated by the absence of a signal for one angular 
methyl group and the presence of signals for a hydroxymethyl 
group as an AB quartet at 3.5 - 3.9 ppm. Consequently V is 
009 I-I 50X/95/2907-0491 $12,50 0 1996 Plenum Publishing Corporation 
492 I .M .  Gei la et ai. 
19-hydroxybufalin, itsPMR spectrum coincides with the data 
of[5]. 
Compounds V I - IX  have the composition C24H320 6 
(MH § = 417). Since there are no signals in their PMR spectra 
for protons located either at a double bond or a 14,15[3-epoxide 
ring, then according to their empirical formula compounds 
VI - IX contain a carbonyl and three hydroxyl groups. A sin- 
glet is observed at 9.99 ppm, characteristic of an aldehyde 
group proton, in the PMR spectrum of VI in place of the signal 
for a 19-CH3 group. The presence of only one signal for a pro- 
ton near a secondary hydroxyl group (br. s. 3ct-H at 4.19 ppm) 
indicates that compound VI is hellebrigenin, its PMR spec- 
trum mainly agrees with that described in [3, 5]. The PMR 
spectrum of compound VII in CDCI3 does not at first sight 
correspond to the structure proposed for the trihydroxycar- 
bonyl compound since there are four signals and not two on 
the low field region 3.8 - 4.4 ppm, where the signals for pro- 
tons at hydroxyl groups are usually observed, viz. 3.81 ppm 
(d, 1H), 4.11 ppm (m, 2H), and 4.32 ppm (d d, I H). The signal 
at 3.81 ppm disappeared in CD3OD, the signal at 4.36 ppm 
was converted into a doublet, and the multiplet at 4. I 1 ppm 
was converted into a quartet at 4.15 ppm (with coupling 
constants 6 and 9 Hz) and a broadened singlet at 4.05 ppm 
(3ct-H). These data are in agreement with the published PMR 
spectrum of arenobufagin [6] wlth assignment of the doublet 
at 3.81 ppm to the proton of the 1 ltz-OH group and the quartet 
at 4.11 ppm to the 17ct-H. 
In the PMR spectrum of compound VIII (about 2 mg iso- 
latecl) there were signals for two pritins at secondary hydrixyl 
groups, a briadened singlet for the 3c~-H at 4.11 ppm and a 
singlet at 3.9 ppm. The signals for the 18- and 19-CH3 groups 
were located at 0.5 and 1.25 ppm. Only bufanenogin (as 
the diacetate) [4] and its 5[3-hydroxy analog, isolated from 
glow-worms [7], have chemical shifts close to those of the an- 
gular methyl groups. Based on this we suggest that compound 
VIII is bufanenogin. The structure of compound IX was not 
established. 
TABLE 1. Composition f the Skin Secretion ofGreen Toads (Bufo virtdis L.) 
Relative content', %
Compound Zorbax CN Zorbax Sil 
1992 1993 1992 1993 
Bufalin 2.7 2.0 
Marinobufagin 20.9 24.7 22.8 23.1 
Telocinobufagin 12.1 10.4 12.8 12.6 
Hellebrigenin'* 5.1 3.0 4.5 2.4 
Arenobufagin 14.4 13. I 14.1 14.8 
Gamabufotalin 36.2 44.9 37.2 43.8 
9 In relative peak area. 
"*Together with 19-hydroxybufalin on Zorbax CN. 
The bufadienolides isolated by us were then used as 
markers in the development of a procedure for the chroma- 
tographic analysis of the total extract ofBufo viridis secretion. 
The method of determining the composition of bufadieno- 
lides developed in [8] comprized extraction of steroids from 
the secretion, preliminary separation of them into three frac- 
tions by TLC, and subsequent analysis by HPLC on a reversed 
phase column (with a different mobile phase composition for 
each fraction). We obtained satisfactory results in a parallel 
analysis of total bufadienolides on a normal phase column of 
Zorbax Sil in CHCl3--ethanol and a reversed phase column of 
Zorbax CN in CH3CN-H20. Conducting the analysis on two 
columns was necessary since 19-hydroxybufalin overlaps 
hellebrigenin on the Zorbax CN column, and bufalin and ma- 
rinobufagin are resolved unsatisfactorily on Zorbax Sil. Paral- 
lel analysis on two different columns provides a complete 
resolution of all the main components of the secretion. Only 
one of the minor components i olated by us, viz. bufanenogin, 
was not determined in these systems since it overlaps ga- 
mabufotalin on the Zorbax CN column and hellebrigenin on 
Zorbax Sil. 
As is evident from the results presented in Table I the 
main component of the secretion is gamabufotalin and the 
composition of the bufadienolides in the specimens investi- 
gated by us differed from the data published previously in 
[9, 10]. Bufalin, marinobofagin, resibufogenin, and cinobu- 
fagin were identified in the secretion from green toads inhab- 
iting the central zone of Russia [9]. These results, which are 
based on qualitative reactions and data of paper chromatogra- 
phy, are unreliable. Karinobufagin, telocinobufagin, helle- 
brigenin, and arenobufagin were identified in [10] as the main 
components of the secretion. The main component of the se- 
cretion was arenobufagin but gamabufotalin was in general 
not detected. 
The green toad is a widespread and extremely polymor- 
phic species. Many of its populations have an obscure taxo- 
nomic status [11]. In addition appreciable intraspecies differ- 
ences in the composition of skin secretions have been recorded 
in the related species Bufo regularis [12]. On this basis we 
suggest that the differences of our results are explained by the 
fact that an appreciably different form ofBufo viridis was stud- 
ied in [ 10]. 
EXPERIMENTAL PART 
Parotid secretion (parotid or suprascapular glands) was 
obtained by the generally accepted procedure [13 ] from adult 
green toads and was dried over CaCI2. The secretion investi- 
gated had been obtained from a representative s lection of 
several hundred specimens of a nominated subspecies of green 
toad (Bufo viridis) collected by us in the Kharkov area in 
May - June 1992 and 1993. For the identification of the bu- 
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fadienolides present in them the bufadienolides and the sterols 
accompanying them were extracted from 10 g dried parotid 
secretion of green toads with a CHC13-CH3OH (4 : 1) mixture. 
The sterols were separated from bufadienolides by distribution 
in the system CH3OH-hexane. The steroids remaining in the 
methanol phase were separated, after evaporation, by chroma- 
tography on silica gel on a CHCI3-C2HsOH gradient. The 
separate fractions were separated into individual compounds 
by preparative HPLC on a reversed phase column. 
Separation and analysis of bufadienolides was carried 
out with a Waters liquid chromatograph with a UV detector 
recordinq at 300 nm. Preparative separation of bufadieno- 
lide fractions was carried out on a column of Diasorb C16 T, 
250 x 10 mm with CH3CN-H2 O as mobile phase. The analyti- 
cal separation was carried out on a column of Zorbax Sil 
4.6 x 150 mm eluting with CHCI3-C2HsOH (96 : 4) and a col- 
umn of Zorbax CN 4.6 • 250 mm eluting with CH3CN-H20 
(25:75). 
Fast atom ionization mass spectra were taken on a 
MI 120l series spectrometer (l~lektron Production Associa- 
tion, Sumy, Ukraine) in a glycerol matrix at a primary beam 
energy of 3.5 keV. The PMR spectra were taken on a 
Broker AC 200 (Germany) spectrometer in CDCI3 and 
CD3OD. 
Crystals of compound IV for x-ray structural investiga- 
tion were obtained by two recrystallizations from acetoni- 
trile and were solvated 1 : 1. The crystal system was thorn- 
bic, At 20~ a = 10.520(3), b = 13.717(5), c = 16.120(4) A, 
V=2326(1)A 3, d=lc---1.327 g/cm 3, space group P212121, 
Z = 4. The unit cell parameters and the intensities of 1450 in- 
dependent reflections with F > 6or(F) were measured on a Sie- 
mens P3,rPC automatic four-circle diffractometer (MoKa ra- 
diation, graphite monochromator, 20max = 50~ 
The structure was refined by the direct method using the 
Sheltx Plus set of programs. 
Compound I (bufalin), white amorphous powder. 
C24H340 4. Mass spectrum, re~z: 387 (MH*). PMR spectrum, 6, 
ppm: 0.7 s (18-Me), 0.946 s (19-Me), 2.43 m (17ct-H), 4.13 s 
(3ct-H), 6.26 d (J = 9.6 Hz), 7.23 d (J = 2.3 Hz), 7.82 d d 
(J = 9.6, 2.3 Hz). 
Compound II (marinobufagin), colorless crystal- 
line product, m. p. 224-226~ (acetone), literature m. p. 
222 -224~ [7]. C24H32Os. Mass spectrum, m/z: 401 (MH+). 
PMR spectrum, 6, ppm: 0.78 s (18-Me), 0.99 s (19-Me), 
3.51 s(15ct-H), 4.19 s (3ct-H), 6.25 d ( J=9.7 Hz), 7.24 d 
(J = 2.7 Hz), 7.78 d d (J = 9.7, 2.7 Hz). 
Compound II I  (teloeingbufagin), colorless crystalline 
product, m. p- 151-  155~ literature m. p. 154-157~ 
/204 - 206~ [3]. C24H340 5. Mass spectrum, m/z: 403 (MH+). 
PMR spectrum, d, ppm: 0.695 s (18-Me), 0.93 s (19-Me), 
2.46 m (1Tot-H), 4.17 s (3cz-H), 6.25 d (J =9.7 Hz), 7.23 d 
(J = 2.5 Hz), 7.83 d d (J = 9.7, 2.5 Hz). 
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Fig. 1. The HPLC of the bufadienolide fraction of green toad secretion 
(collected in 1993) on a column of Zorbax CN 4.6 • 150 mm, mobile 
phase CH3CN-H~O (25 : 75 vol. %). 1.5 ml/min, UV detector, 300 nm. Ab- 
scissa) Retention time, rain *) Unidentified component 
Compound IV (gamabufotalin), colorless crystalline 
product, m. p. 261 - 263~ literature m. p. 261 - 264~ [3]. 
C24H340 5. Mass spectrum, m/z: 403 (MH+). PMR spectrum, 5, 
ppm: 0.74 s (18-Me), 1.075 s (19-Me), 2.52 m (17ct-H), 
3.79 m (1 lI3-H, J = 10.0, 10.0, 4.0 Hz), 4.15 s (3ct-H), 6.26 d 
(J = 9.8 Hz), 7.25 d (J = 2.6 Hz), 7.79 d d (J = 9.8, 2.6 Hz). 
Compound V (19-hydroxybufalin), colorless oil. 
C24H340 5. Mass spectrum, re~z: 403 (MH§ PMR spectrum, 
6, ppm: 0.7 s (18-Me), 2.45 m (17ct-H), 3.49 d and 3.87 d 
(19-CH2, J= 10.9 Hz), 4.13 s (3cz-H), 6.26 d (J= 9.8 Hz), 
7.22 d (J = 2.6 Hz), 7.83 d d (J = 9.8, 2.6 Hz). 
Compound VI (hellebrigenin), colorless amorphous 
product. Cz4H3406. Mass spectrum, m/z: 417 (MH§ PMR 
spectrum, 5, ppm: 0.69 s (18-Me), 2.47 m (17c~-H), 4.19 s 
(3ct-H), 6.26 d ( J=9.7Hz),  7.23 d ( J=2.6Hz),  78 dd 
(J = 9.7, 2.6 Hz), 9.99 s (19-H). 
Compound VII (arenobufagin), colorless crystalline 
product, m. p. 213-215~ (acetone), literature m. p. 
208 - 213~ [6], 222 - 228~ [6]. C24H340 6. Mass spectrum, 
m/z: 417 (MH§ PMR spectrum (CDCI3), d, ppm: 0.92 s 
(18-Me), 1.18 s (19-Me), 3.81 d (11-OH, J=3  Hz), 4.11 m 
(17ct-H, 3ct-H), 4.32 d d (llI3-H, J = 10.8, 3 Hz), 6.29 d 
(J = %8 Hz), 7.39 d (J = 2.6 Hz), 7.72 d d (J = 9.8, 2_6 Hz). 
PMR spectrum (CD3OD), 5, ppm: 0.9 s (18-Me), 1.t7 s 
(19-Me), 4.05 s (3ct-H), 4.15 dd  (17ct-H, J =9.0, 6.0 Hz), 
4.36 d (ll13-H, J=10.5Hz),  6.3 d ( J=10Hz) ,  7.5 d 
(J = 2.9 Hz), 7.96 d d (J = I0, 2.9 Hz). 
Compound VIII (bufanenogin), amorphous product. 
C24H340 6. Mass spectrum, m/z: 417 (MH§ PMR spectrum, 6, 
ppm: 0.5 s (18-Me), 1.25 s (19-Me), 2.63 d (J = 12_2 Hz), 
3.23 d d (17ct-H, J=9.0, 6,0 Hz), 3.9 s (12ct-H), 6.25 d 
(J = 9.7 Hz), 7.36 d (J = 2.8 Hz), 7.7 d d (J -- 9.7, 2.8 Hz). 
494 I .M.  Gella et al. 
REFERENCES 
I. N. Horiger, D. Zivanov, H. H. A. Linde, and K. Meyer, Helv. 
Chim Acta, 55, 2549-  2562 (1972). 
2. B. S. Low, "Evidence from parotid gland secretions," in: Evolu- 
tion in Genus Bufo, Dallas ( 1972), pp. 244 - 265. 
3. J. D. Wang, T. Narui, S. Takatsuki, et al., Chem. Pharm. Bull., 
39(8), 2135 - 2137 (1991). 
4. L. Gsell and C. Tamm, Helv. Chim. Acta, 52, 551 - 560 (1969). 
5. R. Verpoorte, Phan-quoc-Kihn, and A. B. Svendsen, J. Nat. 
Products, 43(3), 347 - 352 (1980). 
6. J. Meinwald, D. F. Weimer, and T. Eisner, J. Am. Chem. Soc., 
101(I 1 ), 3055 - 3060 (1979). 
7. M. G6tz, D. F. Wiemer, W. Le Roy Haynes, et al., Helv. Chim. 
Acta, 62(5), 1396 - 1400 (1979). 
8. K. Shimada, M. Hasegawa, K. Hasebe, et al., Chem. Pharm. 
Bull., 24(12), 2995 -3000 (1976). 
9. V. N. Ka-ylov, L. V. Yunina, and I. I. Lysova, Mechanisms of 
Action of Zootoxins [in Russian], Gorky (1977), pp. 150 - 154. 
10. K. Shimada, N. Ishii, and T. Nambara, Chem. Pharm. BulL, 
34(8), 3453 - 3457 (1976). 
11. P. Roth, "An overview of the systematics of the Bufo viridis 
group in Middle and Central Asia," in: Studies of Herpetology, 
Prague (1986), pp 130- 136. 
12. B. S. Low, Comp Biochem. Physiol., 26, 245 - 257 (1968). 
13. B. N. Orlov, D. 13. Gelashvili, and A. K. Ibragimov, Poisonous 
Animals and Plants of the USSR [in Russian], Moscow (1990). 
